GelteqGELS +2.16%8 Gross Margin % is 0.00% as of Jun. 2025. GuruFocus rates GELS with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 938 Drug Manufacturers companies, Gelteq ranks worse than 106609.7% on this metric.
The historical rank and industry rank for Gelteq's Gross Margin % or its related term are showing as below:
During the past 6 years, the highestGross Margin % of Gelteq was 38.89%. The lowest was 35.58%. And the median was 37.24%.
GELS's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.44 * Ranked among companies with meaningful Gross Margin % only.
Gelteq had a gross margin of N/A% for the quarter that ended in Jun. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Gelteq was 0.00% per year.
Gelteq (NAS:GELS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Gelteq had a gross margin of N/A% for the quarter that ended in Jun. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Gelteq Gross Margin % Related Terms
Gelteq Gross Margin % Historical Data
* Premium members only.
The historical data trend for Gelteq's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GELS vs INM, LVRLF, BUDZ: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Gelteq's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gelteq Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gelteq's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Gelteq's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Gelteq (GELS) has a Gross Margin % of 0.00% as of Jun. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Gelteq and its competitors. Over the past decade, Gelteq's Gross Margin % has ranged from 35.58 to 38.89. According to the industry distribution chart, Gelteq ranks #999999 out of 938 companies in the Drug Manufacturers industry.
Is Gelteq's Gross Margin % too high?
Gelteq's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 35.58 to a high of 38.89. Based on the distribution chart, Gelteq ranks #999999 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Gelteq has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's Gross Margin % compare to INM and LVRLF?
According to the Drug Manufacturers industry distribution chart, Gelteq ranks #999999 out of 938 companies for Gross Margin %. This places Gelteq in the lower half of its industry. The industry median Gross Margin % is 48.44. Historically, Gelteq's own Gross Margin % has ranged from 35.58 to 38.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Gelteq and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gelteq's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Gelteq's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Gelteq (GELS), the current Gross Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
8GF Score
Get the complete analysis for GELS
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GELS has been successfully added to your 